Literature DB >> 10372118

Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors.

H E Broxmeyer1, C H Kim, S H Cooper, G Hangoc, R Hromas, L M Pelus.   

Abstract

Chemokines have been implicated in the regulation of stem/progenitor cell proliferation and movement. The purpose of the present study was to assess a number of new chemokines for suppressive activity and to delve further into SDF-1-mediated chemotaxis of progenitor cells. This report extends the list of chemokines that have suppressive activity against immature subsets of myeloid progenitors stimulated to proliferate by multiple growth factors to include: MCP-4/CK beta-10, MIP-4/CK beta-7, I-309, TECK, GCP-2, MIG and lymphotactin. The suppressive activity of a number of other chemokines was confirmed. Additionally, pretreatment of the active chemokines with an acetylnitrile solution enhanced specific activity of a number of these chemokines. The new chemokines found to be lacking suppressive activity include: MCP-2, MCP-3, eotaxin-1, MCIF/HCC-1/CK beta-1, TARC, MDC, MPIF-2/eotaxin-2/CK beta-6, SDF-1 and fractalkine/neurotactin. Overall, 19 chemokines, crossing the CC, CXC, and C subgroups, have now been found to be myelosuppressive, and 14 chemokines crossing the CC, CXC and CX3C subgroups have been found to lack myelosuppressive activity under the culture conditions of our assays. Because of the redundancy in chemokine/chemokine receptor interactions, it is not yet clear through which chemokine receptors many of these chemokines signal to elicit suppressive activities. It was also found that SDF-1-induced chemotaxis of progenitors can occur in the presence of fibronectin (FN) and extracellular matrix components and that FN effects involve activation of beta 1-, and possibly alpha 4-, integrins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372118     DOI: 10.1111/j.1749-6632.1999.tb08460.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  In situ hematopoiesis: a regulator of TH2 cytokine-mediated immunity and inflammation at mucosal surfaces.

Authors:  C C K Hui; K M McNagny; J A Denburg; M C Siracusa
Journal:  Mucosal Immunol       Date:  2015-03-18       Impact factor: 7.313

3.  DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis.

Authors:  David M Hoover; Jacek Lubkowski
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

4.  Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis.

Authors:  Toshio Takano; Yin-Ji Li; Akiko Kukita; Takayoshi Yamaza; Yasunori Ayukawa; Kanako Moriyama; Norihisa Uehara; Hisayuki Nomiyama; Kiyoshi Koyano; Toshio Kukita
Journal:  Lab Invest       Date:  2014-01-06       Impact factor: 5.662

Review 5.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

Authors:  Evemie Schutyser; Ann Richmond; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2005-03-22       Impact factor: 4.962

6.  The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression.

Authors:  M Rosu-Myles; L Gallacher; B Murdoch; D A Hess; M Keeney; D Kelvin; L Dale; S S Ferguson; D Wu; F Fellows; M Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.

Authors:  Erin D Milligan; Carin Twining; Marucia Chacur; Joseph Biedenkapp; Kevin O'Connor; Stephen Poole; Kevin Tracey; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  CXCR4 induction in hematopoietic progenitor cells from Fanca(-/-), -c(-/-), and -d2(-/-) mice.

Authors:  Amy M Skinner; S Lee O'Neill; Markus Grompe; Peter Kurre
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

9.  PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

Authors:  Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.

Authors:  Hal E Broxmeyer; Maegan Capitano; Timothy B Campbell; Giao Hangoc; Scott Cooper
Journal:  Stem Cells Dev       Date:  2016-03-30       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.